News

StarFish Medical Expands Reach by Acquiring Omnica Corporation

StarFish Medical Expands Reach by Acquiring Omnica Corporation

StarFish Medical Expands Reach with New Acquisition

StarFish Medical has taken a significant step toward reinforcing its position as a leading medical device development company by acquiring Omnica Corporation. This move marks the company's second acquisition in seven years and highlights its strategy to enhance operations in a crucial market known for its medical device innovation.

Strengthening Market Presence

The acquisition of Omnica Corporation, based in California, represents a pivotal shift for StarFish Medical. California has long been recognized as a major hub for medical technology advancements, and this acquisition brings StarFish Medical closer to a variety of clients in this influential region.

Local Expertise and Resources

With the addition of Omnica's team, StarFish Medical will bolster its expertise by incorporating the seasoned professionals from Omnica, a company with over 40 years of experience in medical device design and engineering. The integration of these experts will significantly enhance StarFish Medical's capacity to serve its growing client base in California.

Facilities and Capabilities

Omnica's impressive 25,000-square-foot facility, renowned for developing a range of medical products including diagnostics, monitoring equipment, and surgical devices, will now operate under the StarFish Medical umbrella. This facility not only adds valuable space but also enhances the company's production capabilities.

Leadership Perspectives

Scott Phillips, CEO and Founder of StarFish Medical, expressed enthusiasm about the acquisition, stating, "Adding Omnica to the StarFish family brings us closer to our clients in California. Omnica offers a team of experts that rivals our own, and their unmatched prototyping capacity is a valuable asset for us as we support medical technology companies."

A Legacy of Innovation

The legacy of Omnica Corporation, co-founded by Earl Robinson, has been defined by a commitment to innovation and meeting complex medical device needs. Robinson’s retirement was acknowledged as part of this transition, allowing the new partnership with StarFish Medical to flourish and reach new heights.

Future Collaborations

By merging the strengths of both companies, StarFish Medical aims to enhance its innovation efforts, expand its local and regional outreach, and deepen connections with clients across the North American market.

About StarFish Medical

StarFish Medical is a prominent player in the medical device industry, offering award-winning design and development services across various specialties, including Digital Health, Neurology, and In-Vitro Diagnostics. They partner with forward-thinking companies to create groundbreaking medical products, ensuring quality assurance support and compliance with ISO standards.

About Omnica Corporation

Established in 1984, Omnica Corporation is recognized for its expertise in developing intricate medical devices. The company offers a diverse range of services including engineering, product design, and regulatory assistance. Their collaboration with both startups and established industry leaders has enabled them to deliver solutions that truly stand out.

Frequently Asked Questions

What is the significance of StarFish Medical acquiring Omnica Corporation?

This acquisition strengthens StarFish Medical's presence in California, a key market for medical device innovation.

How many acquisitions has StarFish Medical made?

StarFish Medical has made two acquisitions in seven years, including the recent purchase of Omnica Corporation.

What products does Omnica Corporation develop?

Omnica focuses on developing a range of medical products including disposables, diagnostics, and surgical devices.

Who is the CEO of StarFish Medical?

Scott Phillips serves as the CEO and Founder of StarFish Medical.

What areas does StarFish Medical operate in?

StarFish Medical operates in various specialties including Cardiovascular, Neurology, and Digital Health.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

UBCF Extends Pink Bag Event for Breast Cancer Aid

Updated Category News Views 2

Community Need Drives Event Extension October in Jonesboro just got a bit more hopeful for breast cancer survivors—it's not just about awareness anymore; it's about action. The United Breast Cancer Foundation (UBCF) has decided to extend its popular Pink Bag free shopping event through October 30th. What spurred this decision? Well, the overwhelming community demand,...

Continue Reading
AI Tool circMAC Enhances MicroRNA Mapping on circRNAs

Updated Category News Views 3

Mapping the Complex Maze of MicroRNA on Circular RNAs Pusan National University's brainiacs have cooked up something spicy for the bioinformatics world. They've developed this snazzy AI tool, circMAC, to unravel microRNA binding mysteries on circular RNAs. 'Why’s this such a big deal?' you ask. Well, these loop-shaped critters, circRNAs, play a backstage role in gene...

Continue Reading
Podium Surges Past $150M in AI ARR Milestone

Updated Category News Views 3

A New Era for Podium When the brass at Podium made a gamble on AI, they didn't just try squeezing it into their old business model. Oh no, they launched what feels like a startup within their existing empire—no half-measures, just full-throttle ambition. Fast forward two and a half years, and they've racked up over $150 million in annual recurring revenue from these...

Continue Reading
Labcorp, FDA Collaborate to Tackle Drug Abuse Risks

Updated Category News Views 2

Rethinking How We Evaluate Drug Abuse Potential Sometimes, the finance world gets a peek into something that ain't just about the numbers on a screen, something with real stakes beyond the bulls and bears. Labcorp's just thrown its hat in with the FDA and Charles River Laboratories in a collaboration that goes beyond just lining pockets. They're setting up to dissect how...

Continue Reading
Vertice P2P Aims to Transform Procurement Efficiency

Updated Category News Views 9

Vertice Dives Deeper into the Procurement Game Grab a coffee and let's talk some procurement—one of the least sexy, yet utterly essential parts of any operation. Vertice's latest announcement is anything but mundane. They're spiraling deeper into the procurement universe with their new Procure-to-Pay (P2P) capability, a bold expansion from their Intake-to-Procure (I2P)...

Continue Reading
Cognizant AI Nexus Aims to Tame Enterprise AI Chaos

Updated Category News Views 5

AI Investments Without Returns: The Current Scenario Well, wouldn't you know it? Enterprises have sunk a fortune into AI, and they're wagging their fingers once more at the mounting bills with little to show for it. Play the investment game long enough, and it seems you'll find the numbers don't always rub together and make sparks. This familiar tune of over-budget...

Continue Reading
TransPerfect Launches College Bowl Game in Puerto Rico

Updated Category News Views 2

Puerto Rico Welcomes College Football with Open Arms Imagine kicking towards the goalposts while the ocean breeze kisses your face—yep, that's what's happening in Puerto Rico this December. TransPerfect, a heavyweight in language and tech solutions, is rolling out the red carpet for the inaugural TransPerfect San Juan Bowl, and it’s not just a game. It’s a bold step...

Continue Reading
Carrier Drops $600M on U.S. Manufacturing Boost

Updated Category News Views 3

A Mighty Move in Manufacturing Carrier Global Corporation's recent muscle-flexing is something rarer than a golden goose in today's market—a $600 million thrust into beefing up U.S. manufacturing and engineering. You can't help but wonder if this is overzealous optimism or a meticulously calculated power play. Clocks don't tick this loudly without good reason, of...

Continue Reading
Innventure Investors Alert: Securities Investigation Looms

Updated Category News Views 6

Innventure's Murky Waters Just when you think you've seen it all, stuff like this reminds you nothing's safe in the market. The law folks at Stranch, Jennings & Garvey, PLLC are sniffing around Innventure, Inc. (NASDAQ: INV) like bloodhounds to see if there's been some hoodwinking going on. We're talking questions about funny business with a data center deal between...

Continue Reading
Xona's $250M Raise: GPS Transformation Sparks Debate

Updated Category News Views 5

The Satellite Race Heats Up: Xona's Ambitious Leap Hold onto your hats, folks, because Xona's making headlines with a $250 million infusion. This ain't just pocket change—it's part of a rocket-fueled mission to upend the GPS landscape. Imagine a world where GPS is 100 times stronger. That's the pitch, and folks, it's got the market buzzing. Valuation Rocketing: Investor...

Continue Reading

Top 5 Most Recently Viewed Articles

Neural Processor Market Growth Projections Through 2032

Updated Category News Views 106

Market Overview and Growth Insights The neural processor market stands at an impressive crossroads, marked by rapid advancements in artificial intelligence (AI) and machine learning (ML). Recent research indicates that this market, valued at $231.8 million in 2023, is projected to experience substantial growth, expected to reach USD 1085.1 million by 2032, with a...

Continue Reading
Yearlong Elvis Celebration at Westgate Las Vegas Resort

Updated Category News Views 184

Westgate Las Vegas Celebrates Elvis Presley's 90th Birthday Westgate Las Vegas Resort & Casino, a historic property that famously served as Elvis Presley’s home while he was performing in Las Vegas, has officially kicked off a yearlong celebration in honor of the King of Rock 'n' Roll's 90th birthday. This remarkable tribute commenced with a festive atmosphere that...

Continue Reading
Chijet Motor Company Prices $8 Million Public Share Offering

Updated Category News Views 137

Chijet Motor Company Announces Public Offering Pricing Chijet Motor Company, Inc. (NASDAQ: CJET), a dynamic player in the automotive sector focused on both traditional fuel and new energy vehicles (NEVs), has recently revealed the pricing for its public offering. The company has set the public offering price at $0.59 per share, intending to distribute a total of...

Continue Reading
Understanding Your Rights as a Savara Inc. Shareholder

Updated Category News Views 145

Understanding Your Rights as a Shareholder It is crucial for shareholders of Savara Inc. (NASDAQ: SVRA) to be aware of their rights, particularly in light of recent developments regarding the company. Shareholders who acquired shares during the defined class period may have the opportunity to take part in legal actions relating to their investments. Shareholders...

Continue Reading
Alpine Income Property Trust: Recent Performance and Insights

Updated Category News Views 73

Alpine Income Property Trust's New Coverage and Rating Recently, UBS has initiated coverage on Alpine Income Property Trust (NYSE:PINE), assigning it a Neutral rating with a target price of $19.00. Analysts noted that they believe the current stock price reflects the anticipated growth from acquisition opportunities under a moderating 10-year rate. Recent Acquisition...

Continue Reading